Evidence map›Paper›PMID 41256736›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2025

Duodenoduodenostomy as an Attractive Option for Exocrine Drainage in Pancreas Transplantation: Insights From a Single-Center Cohort.

Alba Torroella, Rongrong Hu Zhu, Carlos Castillo-Delgado, Marco Pavesi, Ramón Rull, Emma Folch-Puy, Rocío García, Clara Bassaganyas, Carles Pérez-Serrano, Pedro Ventura-Aguiar and 8 more

Abstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Nurturing a Sustainable Transplantation Journey: the best of ESOT Congress 2025.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alba TorroellaHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Rongrong Hu ZhuHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Carlos Castillo-DelgadoHepatobiliopancreatic Surgery and Abdominal Transplant Unit, Department of General Surgery, Hospital General Plaza de la Salud, Santo Domingo, Dominican Republic.
Marco PavesiBarcelona Clinical Coordinating Center (BCCC) - Fundació Món Clínic, Barcelona, Spain.
Ramón RullHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Emma Folch-PuyExperimental Pathology Department, Institut d'Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones científicas (IIBB-CSIC), Barcelona, Spain.
Rocío GarcíaHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Clara BassaganyasUniversity of Barcelona, Barcelona, Spain.
Carles Pérez-SerranoUniversity of Barcelona, Barcelona, Spain.
Pedro Ventura-AguiarUniversity of Barcelona, Barcelona, Spain.
Enrique Montagud-MarrahiUniversity of Barcelona, Barcelona, Spain.
Víctor Emilio HolguinHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Antonio J AmorUniversity of Barcelona, Barcelona, Spain.
Fritz DiekmannUniversity of Barcelona, Barcelona, Spain.
Ángeles García-CriadoUniversity of Barcelona, Barcelona, Spain.
Juan Carlos García-ValdecasasHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Josep FusterHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.
Joana Ferrer-FàbregaHepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Clinical Institute of Digestive and Metabolic Diseases (ICMDiM), Hospital Clínic Barcelona, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Techniques such as retroperitoneal graft placement have further enhanced the ability to replicate the physiology of the "native" pancreas. In our center, from January 2000, duodenojejunostomy (DJ) was the standard technique for exocrine drainage (n = 337). Herein, we report a series of 188 pancreas transplantations performed between May 2016 to July 2025, using a fully retrocolic graft position, systemic venous drainage and enteric drainage via duodenoduodenostomy. The primary endpoint was the assessment of intestinal events and their impact on graft and patient survival. A total of 14 patients (7.4%) experienced complications, including paralytic ileus (n = 2), intestinal obstruction (n = 4), duodenal dehiscence following pancreas transplantectomy (n = 1), anastomotic dehiscence (n = 5), and anastomotic bleeding (n = 2). Of these, 11 cases required relaparotomy for adhesiolysis (n = 2), internal hernia repair (n = 1), Hartmann's procedure (n = 1), transplantectomy (n = 2), primary leak closure (n = 3), and hemostasis with duodenal re-anastomosis (n = 2). After a median follow-up of 42.8 months [IQR 21.8-71.1], graft survival at 1 and 5 years was 87% and 83.4%, respectively (P = 0.688 vs. DJ group), while patient survival was 100% and 98.2% (P = 0.031 vs. DJ group). Duodenoduodenostomy proved to be a feasible and effective technique, offering competitive outcomes in terms of graft and patient survival.

Indexed as

DrainageDuodenostomyDuodenumPancreas TransplantationAdultAgedAnastomosis, SurgicalFemaleGraft SurvivalHumansMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesTreatment OutcomeYoung Adultduodenoduodenostomyexocrine drainagegraft survivalintestinal complicationspancreas transplantation

Identifiers

PMID41256736
PMCPMC12620303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.